Literature DB >> 9662254

Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.

A Marchetti1, S Pellegrini, G Sozzi, G Bertacca, P Gaeta, F Buttitta, V Carnicelli, P Griseri, A Chella, C A Angeletti, M Pierotti, G Bevilacqua.   

Abstract

Lung cancer is strictly associated with tobacco smoking. Tumours developed in non-smoking subjects account for less than 10% of all lung cancers and show peculiar histopathological features, being prevalently adenocarcinomas. A number of genetic data suggest that their biological behaviour may be different from that of lung tumours caused by smoking, however the number of cases investigated to date is too low to draw definitive conclusions. We have examined the status of p53 and K-ras genes and the presence of loss of heterozygosity (LOH) at the FHIT locus in a series of 35 lung adenocarcinomas that developed in subjects who had never smoked. Results were compared with those obtained in a series of 35 lung adenocarcinomas from heavy-smoking subjects. In the group of non-smoking subjects p53 mutations and LOH at the FHIT locus were present in seven (20%) cases, and the two alterations were constantly associated (P < 0.0001), whereas they were not related in the series of carcinomas caused by smoking. In tumours developed in heavy-smoking subjects, the frequency of LOH at the FHIT locus was significantly higher (P = 0.006) than in tumours from non-smoking subjects. The frequency of p53 mutations in adenocarcinomas caused by smoking was not different from that seen in non-smoking subjects. However, in the group of smoking subjects we observed mostly G:C --> T:A transversions, whereas frameshift mutations and G:C --> A:T transitions were more frequently found in tumours from non-smoking subjects. No point mutations of the K-ras gene at codon 12 were seen in subjects who had never smoked, whereas they were present (mostly G:C --> T:A transversions) in 34% of tumours caused by smoking (P = 0.002). Our data suggest that lung adenocarcinomas developed in subjects who had never smoked represent a distinct biological entity involving a co-alteration of the p53 gene and the FHIT locus in 20% of cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662254      PMCID: PMC2062949          DOI: 10.1038/bjc.1998.445

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  The FHIT gene 3p14.2 is abnormal in lung cancer.

Authors:  G Sozzi; M L Veronese; M Negrini; R Baffa; M G Cotticelli; H Inoue; S Tornielli; S Pilotti; L De Gregorio; U Pastorino; M A Pierotti; M Ohta; K Huebner; C M Croce
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

3.  Lung cancer in nonsmoking women. Histology and survival patterns.

Authors:  R C Brownson; T S Loy; E Ingram; J L Myers; M C Alavanja; D J Sharp; J C Chang
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

4.  DNA alterations in cells from hereditary non-polyposis colorectal cancer patients.

Authors:  C Wu; Y Akiyama; K Imai; S Miyake; H Nagasaki; M Oto; S Okabe; T Iwama; K Mitamura; H Masumitsu
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

5.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

6.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.

Authors:  Z H Li; J Zheng; L M Weiss; D Shibata
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

7.  p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.

Authors:  A Marchetti; F Buttitta; G Merlo; F Diella; S Pellegrini; S Pepe; P Macchiarini; A Chella; C A Angeletti; R Callahan
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

8.  p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking.

Authors:  H Suzuki; T Takahashi; T Kuroishi; M Suyama; Y Ariyoshi; T Takahashi; R Ueda
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

9.  Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.

Authors:  L N Lee; J Y Shew; J C Sheu; Y C Lee; W C Lee; M T Fang; H F Chang; C J Yu; P C Yang; K T Luh
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

10.  p53 mutations in lung cancers from non-smoking atomic-bomb survivors.

Authors:  Y Takeshima; T Seyama; W P Bennett; M Akiyama; S Tokuoka; K Inai; K Mabuchi; C E Land; C C Harris
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  6 in total

Review 1.  Common fragile genes and digestive tract cancers.

Authors:  Tamotsu Kuroki; Yoshitsugu Tajima; Jyunichiro Furui; Takashi Kanematsu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Tobacco smoke: chemical carcinogenesis and genetic lesions.

Authors:  J L Cook
Journal:  Ochsner J       Date:  1999-07

3.  The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.

Authors:  Juliana J Oh; Ashley K Koegel; Diana T Phan; Ali Razfar; Dennis J Slamon
Journal:  Lung Cancer       Date:  2007-07-02       Impact factor: 5.705

4.  Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.

Authors:  J Geradts; K M Fong; P V Zimmerman; J D Minna
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

5.  Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.

Authors:  S Zienolddiny; D Ryberg; M O Arab; V Skaug; A Haugen
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

6.  Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers.

Authors:  Y-L Chang; C-T Wu; J-Y Shih; Y-C Lee
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.